Ovarian cancer: Clinical Practice Guidelines in Oncology™

Robert J. Morgan, Ronald D. Alvarez, Deborah K. Armstrong, Lee May Chen, Larry Copeland, Jeff Fowler, David K. Gaffney, David Gershenson, Benjamin E. Greer, Carolyn Johnston, Johnathan M. Lancaster, Shashikant Lele, Ursula Matulonis, Robert F. Ozols, Steven W. Remmenga, Paul Sabbatini, John Soper, Nelson Teng

Research output: Contribution to journalReview articlepeer-review


Ovarian neoplasms consist of several histopathologic entities, and treatment depends on the specific tumor type. Epithelial ovarian cancer comprises most malignant ovarian neoplasms; however, other pathologic subtypes (such as less common ovarian histopathologies) must be considered. These guidelines discuss epithelial ovarian cancer as well as less common ovarian histopathologies, including germ cell neoplasms, mixed müllerian tumors of the ovary, and ovarian stromal tumors.

Original languageEnglish (US)
Pages (from-to)912-939
Number of pages28
JournalJNCCN Journal of the National Comprehensive Cancer Network
Issue number9
StatePublished - Oct 2006


  • BRCA genotypes
  • CA 125
  • Chemotherapy
  • Cisplatin
  • Epithelial carcinoma
  • Gynecologic malignancy
  • NCCN Clinical Practice Guidelines
  • Ovarian cancer
  • Staging
  • Surgery
  • Taxane
  • Treatment guidelines

ASJC Scopus subject areas

  • Oncology


Dive into the research topics of 'Ovarian cancer: Clinical Practice Guidelines in Oncology™'. Together they form a unique fingerprint.

Cite this